Neovision Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 15
Average round size
info
The average size of a deal this fund participated in
$33M
Portfolio companies 14
Rounds per year 2.14
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.07
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Medical
  • Insurance
  • Information Technology
  • Sales
Summary

Neovision Capital appeared to be the VC, which was created in 2015. The main office of represented VC is situated in the Shanghai. The venture was found in Asia in China.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Neovision Capital, startups are often financed by Shunwei Capital, Redpoint, Ceyuan Ventures. The meaningful sponsors for the fund in investment in the same round are Zhongjin Qichen, Zeyue Capital, Yonyou. In the next rounds fund is usually obtained by Didi Chuxing, Tencent Holdings, PICC Asset Management.

The overall number of key employees were 1.

The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2019.

The fund has exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Rimag, Smartee Denti-Technology, RenRenChe. Among the most successful fund investment fields, there are 3D Technology, Cloud Data Services. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Neovision Capital:
Typical Co-investors
Neovision Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Neovision Capital:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
3.0 Capital -
Blueprint Ventures California, San Francisco, United States
CEE Group -
Elevage Capital Management Dallas, Texas, United States
Equicelar -
Happy Industry China, Jinan, Shandong
Kingsbridge Capital England, London, United Kingdom
Leede Jones Gable Alberta, Calgary, Canada
LWK Ventures California, South Pasadena, United States
Polaris Capital Group Japan, Tokyo
Provident Growth Fund -
RobecoSAM Switzerland, Zürich, Zurich
Savia Capital Aragon, Spain, Zaragoza
SMFL - Sumitomo Mitsui Finance and Leasing Japan, Tokyo
Stacked Capital New York, New York, United States
The Harry and Jeanette Weinberg Foundation Maryland, Owings Mills, United States
ToYo Work Japan, Miyagi Prefecture, Sendai
Unger Group Bavaria, Germany, Weiden

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Maibang Bio

$15M15 Apr 2022 Shanghai, Shanghai, China

Matrixtime Robotics

3D Technology
Artificial Intelligence
Machine Learning
$15M28 Dec 2021 Minhang District, China

ALVA Systems

Artificial Intelligence
Augmented Reality
Cloud Computing
09 Dec 2021 Haidian, Beijing, China

Xgene Pharmaceutical

Biotechnology
Health Care
Pharmaceutical
$40M05 Nov 2021 Shanghai, China

Chineo

01 Oct 2021 Beijing, Beijing, China

PROPRIUM

Health Care
Health Diagnostics
Medical
Medical Device
Sales
$3M22 May 2020 Hangzhou, Zhejiang, China

Allist Pharmaceuticals

Pharmaceutical
$185M24 May 2019 China, Shanghai

Smartee Denti-Technology

3D Technology
Dental
Education
Health Care
Information Technology
25 Mar 2019 Shanghai, China

Medical
19 Feb 2019 China, Beijing

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Neovision Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: